Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

174 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Side population cells in highly enriched CD34-positive cells from peripheral blood progenitor cells identify an immature subtype of hematopoietic progenitor cells but do not predict time to engraftment in patients treated with high-dose therapy.
Josefsen D, Forfang L, Dyrhaug M, Blystad AK, Stokke T, Smeland EB, Kvalheim G. Josefsen D, et al. Among authors: kvalheim g. Eur J Haematol. 2011 Dec;87(6):494-502. doi: 10.1111/j.1600-0609.2011.01681.x. Epub 2011 Sep 15. Eur J Haematol. 2011. PMID: 21752097
Priming with r-metHuSCF and filgrastim or chemotherapy and filgrastim in patients with malignant lymphomas: a randomized phase II pilot study of mobilization and engraftment.
Johnsen HE, Geisler C, Juvonen E, Remes K, Juliusson G, Hörnsten P, Kvaloy S, Kvalheim G, Jürgensen GW, Pedersen LM, Bergmann OJ, Schmitz A, Boegsted M. Johnsen HE, et al. Among authors: kvalheim g. Bone Marrow Transplant. 2011 Jan;46(1):44-51. doi: 10.1038/bmt.2010.84. Epub 2010 May 3. Bone Marrow Transplant. 2011. PMID: 20436517 Clinical Trial.
Infused CD34 cell dose, but not tumour cell content of peripheral blood progenitor cell grafts, predicts clinical outcome in patients with diffuse large B-cell lymphoma and follicular lymphoma grade 3 treated with high-dose therapy.
Blystad AK, Delabie J, Kvaløy S, Holte H, Vålerhaugen H, Ikonomou I, Kvalheim G. Blystad AK, et al. Among authors: kvalheim g. Br J Haematol. 2004 Jun;125(5):605-12. doi: 10.1111/j.1365-2141.2004.04951.x. Br J Haematol. 2004. PMID: 15147376 Free article.
The mild inflammatory response in febrile neutropenic lymphoma patients with low risk of complications is more pronounced in patients receiving tobramycin once daily compared with three times daily.
Torfoss D, Sandstad B, Mollnes TE, Høiby EA, Holte H, Bjerner J, Bjøro T, Gaudernack G, Kvalheim G, Kvaløy S. Torfoss D, et al. Among authors: kvalheim g. Scand J Immunol. 2011 Dec;74(6):632-9. doi: 10.1111/j.1365-3083.2011.02618.x. Scand J Immunol. 2011. PMID: 21883353 Free article. Clinical Trial.
174 results